最近の記事
- 2021/10/12
- 三重大学大学院医学系研究科生命医科学専攻（修士課程・博士課程）
- 2021/07/01
- ゼブラフィッシュとヒトの自然流産
- 2021/06/30
- ゼブラフィッシュ創薬の自動化は、自動運転レベルを追撃する。
- 2021/06/29
- ハイスループット発生毒性試験を、始めよう。
- 2021/06/29
- 西堀先生との長いお付き合い
- 2021/04/23
- ゼブラフィッシュDX(デジタルトランスフォーメーション)
| 2014/12/10 |
|
Next Generation Zebrafish-Driven Drug Discovery System and Personalized Medicine
We have developed zebrafish-based quantitative and systems pharmacology, which synergistically combine the desirable features of systems pharmacology and emerging technology of zebrafish-based screening system for functional omics and chemical biology. Zebrafish-based systems pharmacology that analyze in vivo regulatory networks involved in drug action can account for a drug’s multiple targets and for the effects of genomic, epigenomic, and posttranslational changes on the drug efficacy. The next generation discipline of systems pharmacology aims to combine experimental analysis and computational modeling of in vivo networks with quantitative pharmacology approaches to drive the drug discovery processes, predict rare adverse events, and catalyze the practice of personalized medicine. This new systems pharmacology can drive drug discovery and personalized medicine.
関連リンク
